Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Invesco India Pharma and Healthcare Fund · Regular ✕Edelweiss Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseInvescoEdelweiss
NAV₹10.7400₹9.2021
NAV date20 Nov 202620 Nov 2026
History2 months2.3 years
Expense ratio3.8%2.7%
StarsNot ratedNot rated
Growth Score——

Returns

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
1 month+19.60%+5.71%
3 months—+0.80%
6 months—+4.95%
YTD—+1.69%
1 year—+2.20%
3 years (CAGR)——
5 years (CAGR)——
10 years (CAGR)——
Since launch+7.29%−3.74%

Risk

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
Volatility——
Downside volatility——
Sharpe——
Sortino——
Calmar——
Return / risk——
Deepest fall−11.50%−26.91%
Days to recover14—
Below its high+0.00%−10.68%

Against benchmark

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
Alpha——
Beta——
R²——
Up capture——
Down capture——
Tracking error——
Information ratio——
Treynor——

Consistency

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
Best 1-year—+19.06%
Middle 1-year—−0.57%
Worst 1-year—−16.02%
1-year periods with a loss—51.7%
Middle 3-year——
Positive months——
Best day+3.52%+4.77%
Worst day−2.74%−3.86%
Worst 5% day−1.46%−2.02%
Positive days46.8%53.1%
NAVs a year48247

SIP of ₹10,000 a month

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR——
1-year XIRR—+7.48%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth